New Classes of AChE Inhibitors with Additional Pharmacological Effects of Interest for the Treatment of Alzheimer's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|25|3177-3184

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.25, 2004-10, pp. : 3177-3184

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In Silico Analysis of Green Tea Polyphenols as Inhibitors of AChE and BChE Enzymes in Alzheimer’s Disease Treatment

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 15, Iss. 5, 2016-05 ,pp. : 624-628

Bentham Science Publishers

Access to resources Recommend Favorite

Common SAR Derived from Linear and Non-linear QSAR Studies on AChE Inhibitors used in the Treatment of Alzheimer#39;s Disease

By  

Current Neuropharmacology, Vol. 15, Iss. 8, 2017-11 ,pp. : 1093-1099

Bentham Science Publishers

Access to resources Recommend Favorite

Natural AChE Inhibitors from Plants and their Contribution to Alzheimer’s Disease Therapy

By  

Current Neuropharmacology, Vol. 11, Iss. 4, 2013-07 ,pp. : 388-413

Bentham Science Publishers

Access to resources Recommend Favorite

Cholinesterase Inhibitors Used in the Treatment of Alzheimer’s Disease: The Relationship Between Pharmacological Effects and Clinical Efficacy

By Wilkinson D.G.  

Drugs & Aging, Vol. 21, Iss. 7, 2004-01 ,pp. : 453-478

Adis International

Access to resources Recommend Favorite

Tacrine-Huperzine A Hybrids (Huprines) A New Class of Highly Potent and Selective Acetylcholinesterase Inhibitors of Interest for the Treatment of Alzheimer Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 2, 2001-07 ,pp. : 163-174

Bentham Science Publishers

Access to resources Recommend Favorite